<DOC>
	<DOCNO>NCT02089997</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy sodium risedronate tablet ( Benet 75 mg Tablets ) osteoporosis patient daily medical practice , well examine `` status treatment compliance '' - i.e. , whether sodium risedronate tablet take properly accordance prescribe once-monthly regimen</brief_summary>
	<brief_title>Special Drug Use Surveillance Long-term Use Sodium Risedronate Tablets ( Benet 75 mg Tablets ) ( 12-month Treatment Survey )</brief_title>
	<detailed_description>This surveillance design evaluate safety efficacy sodium risedronate tablet ( Benet 75 mg Tablets ) well evaluate status treatment compliance osteoporosis patient daily medical practice . The usual dosage adult 75 mg sodium risedronate administer orally sufficient volume ( approximately 180 mL ) water monthly waking . For least 30 minute administration , patient avoid lie supine position avoid take food , drink ( except water ) oral drug . For detail , see `` Precautions related dosage administration '' section package insert .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Osteoporosis patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>